Review Article

Cardiac Manifestations in COVID-19 Patients: A Focus on the Pediatric Population

Table 1

Cardiac-related clinical descriptions of pediatric patients with COVID-19.

ReferenceNumber of casesCountryAgeSexPhysical examECGEchoElevated labsImagingTreatmentOutcome

[19]1China55 dFTachycardia, respiratory distress, pharyngeal hyperemia, coughNANATroponin, CK-MB, procalcitoninGround-glass opacities, pneumoniaIVIG, inhaled interferon alfa 1b, glutathione, Chinese lotus qingwenSurvived
[20]1China13 mMCough, cracklesNAHeart failureCRP, creatinine kinase, D-dimer, IL6, interferon-gamma,Multiple patch-like shadows, pneumoniaVirazole, oseltamivir, interferon, IVIG, steroids, oxygen therapy, mechanical ventilationSurvived
[21]9China11 m-10 y3MProductive coughNANACK-MB, Pro-BNP, D-dimerPulmonary consolidation, ground-glass opacitiesInhaled interferon, ribavirin, lopinaviritonavirNA
[17]13/2135China0–18 y12MNANAHeart failureNANANANA
[22]3USA6–13 y2MTachycardia, tachypnea, hypotension, systolic murmur, dyspneaSinus tachycardiaDepressed function, MR, flow reversal in descending aorta, pericardial effusionProcalcitonin, D-dimer, fibrinogen, troponin, CRP, LDHNAIL6 inhibitor, IVIG, hydroxychloroquineSurvived
[23]21France3–17 y9MCoughQT prolongation, ST-segment elevation, ventricular arrhythmiaCoronary artery dilatation, myocarditis, pleural effusion, depressed ejection fractionCRP, procalcitonin, IL6, Pro-BNP, D-dimerLocal patchy shadows, ground-glass opacities, interstitial abnormalitiesIVIG, aspirin, corticosteroids, inotropes, oxygen support, mechanical ventilationSurvived
[24]1USA6 yFSyncope, respiratory distress, hypotensionJunctional rhythmDepressed ejection function, MRCRP, procalcitonin, Pro-BNP, D-dimerDiffuse patchy infiltratesAspirin, IVIG, inotropic support, oxygen support, ECMOSurvived
[25]99USA0–20 y53MHypotension, cough, shortness of breath, wheezingNAVentricular dysfunction, pericardial effusion, CAATroponin, Pro-BNP, D-dimer, CRP, fibrinogen, ferritin, ESROpacities, pleural effusionCorticosteroids, IVIG, oxygen support, inotropic support, ECMO2/99 died
[26]186USA0–20 y115MNANACoronary artery dilatation, CAA, depressed EF, pericardial effusionPro-BNP, troponin, D-dimer, fibrinogen, INRNAIL6 inhibitors, IL1Ra inhibitor, IVIG, corticosteroids mechanical ventilation, ECMO, vasopressor support, oxygen support4/186 died
[27]15USA3–20 y11MCough, dyspnea, chest pain, tachycardia, hypotensionVentricular tachycardia, and ectopy, diffuse ST elevationDepressed LV/biventricular function, coronary artery ectasia and dilatation, cardiogenic shockTroponin, Pro-BNP, fibrinogen, CRP, D-dimer, procalcitonin, IL6, IL8, TNF alfaGround-glass opacities, pleural effusionIVIG, steroids, anakinra, remdesivir, inotropic support, anticoagulation, mechanical ventilation, ECMO, intraaortic balloon pump, tocilizumab, COVID-19 convalescent plasma,1/15 died
[28]5France and Switzerland2–16 y18MRespiratory distress, chest painVentricular arrhythmia, nonspecific ST elevationCardiogenic shock, LV dysfunction and hypokinesis, coronary artery dilatation, pericardial effusionTroponin, creatinine kinase, Pro-BNP, D-dimer, CRP, procalcitonin, IL6NAInotropic support, mechanical ventilation, ECMO, IVIG, steroids, anakinraSurvival
[29]4USA3–20 y3MTachycardiaLow voltage nonspecific T-wave changes, right axis deviation, ST-segment elevation, QTc prolongationMyocarditis, MR, depressed LV and RV functions, pericardial effusionCRP, ferritin, troponin, pro-BPN, D-dimer, ferritin, fibrinogenNAIVIG, anticoagulation, tocilizumab, convalescent plasma, mechanical ventilation, ECMO1/4 died
[30]1USA6 mFTachycardia, tachypneaNANormalESR, CRPOpacitiesAspirin, IVIGSurvived
[31]156France5–11 y77MNANAMyocarditisNANAMechanical ventilation, inotropic support1/156 died